Molecular Mass GTP-binding Proteins Research Articles

Novel aspects of the regulation of a cDNA (Arf1) from Chlamydomonas with high sequence identity to animal ADP-ribosylation factor 1

ADP-ribosylation factor (ARF) is a highly conserved, low molecular mass (ca. 21 kDa) GTP-binding protein that has been implicated in vesicle trafficking and signal transduction in yeast and mammalian cells. However, little is known of ARF in plant systems. A putative ARF polypeptide was identified in subcellular fractions of the green alga Chlamydomonas reinhardtii, based on [32P]GTP binding and immunoblot assays. A cDNA clone was isolated from Chlamydomonas (Arf1), which encodes a 20.7 kDa protein with 90% identity to human ARF1. Northern blot analyses showed that levels of Arf1 mRNA are highly regulated during 12 h/12 h light/dark (LD) cycles. A biphasic pattern of expression was observed: a transient peak of Arf1 mRNA occurred at the onset of the light period, which was followed ca. 12 h later by a more prominent peak in the early to mid-dark period. When LD-synchronized cells were shifted to continuous darkness, the dark-specific peak of Arf1 mRNA persisted, indicative of a circadian rhythm. The increase in Arf1 mRNA at the beginning of the light period, however, was shown to be light-dependent, and, moreover, dependent on photosynthesis, since it was prevented by DCMU. We conclude that the biphasic pattern of Arf1 mRNA accumulation during LD cycles is due to regulation by two different factors, light (which requires photosynthesis) and the circadian clock. Thus, these studies identify a novel pattern of expression for a GTP-binding protein gene.

Lipid modification of low molecular mass GTP binding proteins

The in vitro substrate preferences of recombinant S. cerevisiae protein farnesyltransferase and type-I protein geranylgeranyltransferase were determined. Proteins ending in 16 different CaaX sequences (C = cysteine, a = aliphatic amino acid, X= variable amino acids) were used to determine the protein substrate preferences of these S. cerevisiae prenyltransferases. The identites of the attached prenyl groups were confirmed by iodomethane treatment of prenylated substrates and reverse-phase HPLC. The CaaX preference of each recombinant yeast enzyme was found to be nearly identical to the reported preferences of purified mammalian protein farnesyltransferase and type-I protein geranylgeranyltransferase. S. cerevisiae farnesyltransferase preferentially farnesylated CaaX sequences ending in methionine, cysteine or serine. The farnesyltransferase also attached geranylgeranyl to some CaaX sequences ending in methionine, leucine and cysteine. The S. cerevisiae type-I geranylgeranyltransferase preferentially geranylgeranylated CaaX sequences ending in leucine and to a lesser degree methionine. Yeast extracts were found to contain prenylating activities identical to those observed with the recombinant enzymes. Farnesyltransferase activity in yeast extracts exceeded type-I geranylgeranyltransferase activity by at least 3-fold, resulting in prenylation of leucine-ending CaaX substrates with a mixture of 75% geranylgeranyl and 25% farnesyl. These results suggest that some substrate overlap may occur between the S. cerevisiae protein farnesyltransferase and the type-I protein geranylgeranyltransferase in vivo.

Small G proteins and the neutrophil NADPH oxidase

The NADPH oxidase of phagocytic cells is a multimeric enzyme complex activated during phagocytosis. It catalyzes the production of the superoxide anion, precursor of many toxic oxygen metabolites involved in the defense against microorganisms. The enzyme becomes active after assembly on a membrane bound flavocytochrome b of cytosolic factors p47 phox, p67 phox and p40 phox and of low molecular mass GTP binding proteins. This paper reviews recent results concerning the role of two small G proteins, Rac and Rap 1A in oxidase activation. Native prenylated small G proteins are either in the form of a complex in which the GDP bound G protein is associated with a guanine nucleotide dissociation inhibitor, GDI, or in an active GTP bound form able to trigger the activity of its effector. Rac and Rho share a common GDI. As chemotaxis, under Rho control, and oxidase activation, under Rac control, show mutually exclusive signalling pathways, we propose a model where the GDI would switch from one pathway to the other by sequestering either Rac or Rho.